U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Chhabra RS, Pearse G, Bristol DW, et al. NTP Genetically Modified Model Report on the Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal Studies): NTP GMM 10 [Internet]. Research Triangle Park (NC): National Toxicology Program; 2007 Mar.

Cover of NTP Genetically Modified Model Report on the Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal Studies)

NTP Genetically Modified Model Report on the Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal Studies): NTP GMM 10 [Internet].

Show details

REFERENCES

  1. The Aldrich Library of 13C and 1H FT-NMR Spectra (1993). 1st ed., p. 1412(C). Aldrich Chemical Co., Inc., Milwaukee, WI.
  2. The Aldrich Library of FT-IR Spectra (1985). 1st ed. (C.J. Pouchert, Ed.), Vol. 1, p. 876 (A). Aldrich Chemical Co., Inc., Milwaukee, WI.
  3. The Aldrich Library of Infrared Spectra (1981). 3rd ed. (C.J. Pouchert, Ed.), Vol. 1, spectrum 524C (1). Aldrich Chemical Co., Inc., Milwaukee, WI.
  4. Aldrich Technical Information Bulletin No. AL-168: 1,3-Diisopropylcarbodiimide (DIC) (1988). Aldrich Chemical Co., Inc., Milwaukee, WI
  5. Anonymous (1977). Spectrosc. Lett. 10, 959–970.
  6. Azzi, A., Casey, R.P., and Nalecz, M.J. (1984). The effect of N,N’-dicyclohexylcarbodiimide on enzymes of bioenergetic relevance. Biochim. Biophys. Acta 768, 209–226. [PubMed: 6095905]
  7. Bates, H.S., Jones, J.H., Ramage, W.I., and Witty, M. (1981). Some observations on the activation of alkoxycarbonylamino acids by diisopropylcarbodiimide. In Peptides, Proceedings of the 16th European Peptide Symposium (K. Brunfeldt, Ed.), pp. 185–190.
  8. Boorman, G.A., Montgomery, C.A., Jr., Eustis, S.L., Wolfe, M.J., McConnell, E.E., and Hardisty, J.F. (1985). Quality assurance in pathology for rodent carcinogenicity studies. In Handbook of Carcinogen Testing (H.A. Milman and E.K. Weisburger, Eds.), pp. 345–357. Noyes Publications, Park Ridge, NJ.
  9. Boorman, G.A., Hickman, R.L., Davis, G.W., Rhodes, L.S., White, N.W., Griffin, T.A., Mayo, J., and Hamm, T.E., Jr. (1986). Serological titers to murine viruses in 90-day and 2-year studies. In Complications of Viral and Mycoplasmal Infections in Rodents to Toxicology Research and Testing (T.E. Hamm, Jr., Ed.), pp. 11–23. Hemisphere Publishing Corporation, Washington, DC.
  10. Buckles, L.C., and Lewis, S.M. (1977). S-(2-Diisopropylamino-ethyl)-O-ethyl methylphosphonothioate stabilized with soluble carbodiimides. U.S. Patent No. 4012464.
  11. Budnick, E.G. (1968). Triarylarsines as catalysts for converting isocyanates to carbodiimides. U.S. Patent No. 3406198.
  12. Cannon, R.E., Spalding, J.W., Trempus, C.S., Szczesniak, C.J., Virgil, K.M., Humble, M.C., and Tennant, R.W. (1997). Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice. Mol. Carcinog. 20, 108–114. [PubMed: 9328441]
  13. Chadwick, D.H., and Cleveland, T.H. (1979). Isocyanates, Organic. In Kirk-Othmer Encyclopedia of Chemical Technology, 3rd ed. (M. Grayson, D. Eckroth, H.F. Mark, D.F. Othmer, C.G. Overberger, and G.T. Seaborg, Eds.), Vol. 13, pp. 797–799. John Wiley and Sons, New York.
  14. Chhabra, R.S., Bucher, J.R., Wolfe, M., and Portier, C. (2003). Toxicity characterization of environmental chemicals by the U.S. National Toxicology Program: An overview. Int. J. Hyg. Environ. Health 206, 437–445. [PubMed: 12971699]
  15. Code of Federal Regulations (CFR) 21, Part 58. [PubMed: 11660820]
  16. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221. [PubMed: 1552940]
  17. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096–1121.
  18. Ellis, H.V. (1991). Treatment for eye irritants. Chem. Eng. News 69, 2.
  19. Furumoto, S. (1971a). Novel method for the synthesis of carbodiimide. Nippon Kagaku Zasshi 92, 357–360.
  20. Furumoto, S. (1971b). Novel method for the synthesis of carbodiimide. Nippon Kagaku Zasshi 92, 1005–1007.
  21. Gart, J.J., Chu, K.C., and Tarone, R.E. (1979). Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. JNCI 62, 957–974. [PubMed: 285297]
  22. Harris, C.C. (1996a). Structure and function of the p53 tumor suppresor gene: Clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88, 1442–1455. [PubMed: 8841019]
  23. Harris, C.C. (1996b). p53 tumor suppressor gene: From the basic research laboratory to the clinic—an abridged historical perspective. Carcinogenesis 17, 1187–1198. [PubMed: 8681432]
  24. Harris, C.C. (1996c). The 1995 Walter Hubert Lecture – molecular epidemiology of human cancer: Insights from the mutational analysis of the p53 tumour-suppressor gene. Brit. J. Cancer 73, 261–269. [PMC free article: PMC2074430] [PubMed: 8562328]
  25. Hollander, M., and Wolfe, D.A. (1973). Nonparametric Statistical Methods, pp. 120–123. John Wiley and Sons, New York.
  26. Izdebski, J., and Pelka, J. (1984). Peptide synthesis using disubstituted carbodiimides which form dichloromethane-soluble urea derivatives. In Peptides, Proceedings of the 18th European Peptide Symposium, (U. Ragnarsson, Ed.) pp. 113–116.
  27. The Janssen Chimica Catalog Handbook of Fine Chemicals for Research and Industry 1991-1992 (1990). p. 457, Janssen Chemica or Spectrum Chemical Manufacturing Corp., Research Triangle Park, NC.
  28. Kricheldorf, H.R., Au, M., and Mang, T. (1985). Models of molecular evolution. 2. Stereospecificity of dipeptide syntheses by means of cyanamides and carbodiimides. Int. J. Pept. Protein Res. 2, 149–157. [PubMed: 4066152]
  29. Kuney, J.H., Ed. (1990). Chemcyclopedia 91: The Manual of Commercially Available Chemicals, p. 409. American Chemical Society, Washington, DC.
  30. Leder, A., Kuo, A., Cardiff, R.D., Sinn, E., and Leder, P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. 87, 9178–9182. [PMC free article: PMC55127] [PubMed: 2251261]
  31. Mahler, J.F., Stokes, W., Mann, P.C., Takaoka, M., and Maronpot, R.R. (1996). Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24, 710–716. [PubMed: 8994298]
  32. Mahler, J.F., Flagler, N.D., Malarkey, D.E., Mann, P.C., Haseman, J.K., and Eastin, W. (1998). Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice. Toxicol. Pathol. 26, 501–511. [PubMed: 9715509]
  33. Maronpot, R.R., and Boorman, G.A. (1982). Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10, 71–80. [PubMed: 28094716]
  34. Miller, M.J. (1980). Isourea-mediated preparation of dehydro amino acids. J. Org. Chem. 45, 3131–3132.
  35. Minnema, L., and Van der Zande, J.M. (1988). Pattern generation in polyimide coatings and its application in an electrophoretic image display. Polym. Eng. Sci. 28, 815–822.
  36. Moore, J.S., and Stupp, S.I. (1990). Room temperature polyesterification. Macromolecules 23, 65–70.
  37. Morita, T., Asano, N., Awogi, T., Sasaki, Y.F., Sato, S., Shimada, H., Sutou, S., Suzuki, T., Wakata, A., Sofuni, T., and Hayashi, M. (1997). Evaluation of the rodent micronucleus assay in the screening of IARC cacinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group. Mutat. Res. 389, 3–122 (Erratum, 1997, 391, 259–267). [PubMed: 9062586]
  38. Moyer, R.C. (1990). A carbodiimide eye irritant. Chem. Eng. News 68, 2.
  39. Murphy, A.J. (1981). Kinetics of the inactivation of the ATPase of sarcoplasmic reticulum by dicyclohexylcarbodiimide. J. Biol. Chem. 256, 12,046–12,050. [PubMed: 6457831]
  40. Nasr, M.L., Goldman, M., Klein, A.K., and Dacre, J.C. (1988). SCE induction in Chinese hamster ovary cells (CHO) exposed to G agents. Mutat. Res. 204, 649–654. [PubMed: 3352646]
  41. National Institute of Standards Technology (NIST) (1995). Finnigan MATTM NISTTM Library for GCQ/ICIS.
  42. National Toxicology Program (NTP) (2007). Toxicology and Carcinogenesis Studies of Diisopropylcarbodiimide (CAS No. 693-13-0) in F344/N Rats and B6C3F1 Mice (Dermal Studies). Technical Report No. 523, NIH Publication No. 07-4473. National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park, NC. [PubMed: 17554397]
  43. Nutt, R.F. (1978). Cyclization of peptides; reaction of an oligopeptide with isopropylcarbodiimide bound to polystyrene. U.S. Patent No. 4102877.
  44. Ojima, I., Inaba, S., and Nagai, Y. (1974). Syntheses of N-silylformamidines by the hydrosilylation of carbodiimides. Organometal. Chem. 72, C11–C13.
  45. Orlowska, A., Holodowicz, E., and Drabarek, S. (1983). Comparison of dicyclohexylcarbodiimide and diisopropylcarbodiimide as coupling reagents in solid phase peptide syntheses. Pol. J. Chem. 56, 1067–1070.
  46. Paxton, R.J., Jakowatz, J.G., Beatty, J.D., Beatty, B.G., Vlahos, W.G., Williams, L.E., Clark, B.R., and Shively, J.E. (1985). High-specific-activity lllIn-labeled anticarcinoembryonic antigen monoclonal antibody: Improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates. Cancer Res. 45, 5694–5699. [PubMed: 4053042]
  47. Pritchard, J.B., French, J.E., Davis, B.J., and Haseman, J.K. (2003). The role of transgenic mouse models in carcinogen identification. Environ. Health Perspect. 111, 444–454. [PMC free article: PMC1241426] [PubMed: 12676597]
  48. Rao, G.N., Haseman, J.K., and Edmondson, J. (1989a). Influence of viral infections on body weight, survival, and tumor prevalence in Fischer 344/NCr rats on two-year studies. Lab. Anim. Sci. 39, 389–393. [PubMed: 2554057]
  49. Rao, G.N., Piegorsch, W.W., Crawford, D.D., Edmondson, J., and Haseman, J.K. (1989b). Influence of viral infections on body weight, survival, and tumor prevalence of B6C3F1 (C57BL/6N × C3H/HeN) mice in carcinogenicity studies. Fundam. Appl. Toxicol. 13, 156–164. [PubMed: 2767355]
  50. Registry of Toxic Effects of Chemical Substances (RTECS) [database online] (1991a). Cyanamide. Bethesda, MD: National Institute for Occupational Safety and Health; 1971 to present. Updated quarterly. Available from the National Library of Medicine, Bethesda, MD.
  51. Registry of Toxic Effects of Chemical Substances (RTECS) [database online] (1991b). Carbodiimide, diisopropyl. Bethesda, MD: National Institute for Occupational Safety and Health; 1971 to present. Updated quarterly. Available from the National Library of Medicine, Bethesda, MD.
  52. Sabatier, J.M., Tessier-Rochat, M., Granier, C., Van Rietschoten, J., Pedroso, E., Grandas, A., Albericio, F., and Giralt, E. (1987). Convergent solid phase peptide synthesis. VI. Synthesis by the FMOC procedure with a modified protocol of two protected segments, sequence 5-17 and 18-31 of the neurotoxin II of the scorpion Androctonus australis Hector. Tetrahedron 43, 5973–5980.
  53. Satre, M., Lunardi, J., Pougeois, R., and Vignais, P.V. (1979). Inactivation of Escherichia coli BF1-ATPase by dicyclohexylcarbodiimide. Chemical modification of the beta-subunit. Biochemistry 18, 3134–3140. [PubMed: 37896]
  54. Smeltz, K.C. (1969). Catalysts for preparing carbodiimides. U.S. Patent No. 3426025.
  55. Spalding, J.W., Momma, J., Elwell, M.R., and Tennant, R.W. (1993). Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-HA-ras gene. Carcinogenesis 14, 1335–1341. [PubMed: 8330346]
  56. Spalding, J.W., French, J.E., Tice, R.R., Furedi-Machacek, M., Haseman, J.K., and Tennant, R.W. (1999). Development of a transgenic mouse model for carcinogenesis bioassays: Evaluation of chemically induced skin tumors in Tg.AC mice. Toxicol. Sci. 49, 241–254. [PubMed: 10416269]
  57. Tennant, R.W., French, J.E., and Spalding, J.W. (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103, 942–950. [PMC free article: PMC1519166] [PubMed: 8529591]
  58. Tennant, R.W., Spalding, J., and French, J.E. (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res. 365, 119–127. [PubMed: 8898993]
  59. Tennant, R.W., Stasiewicz, S., Mennear, J., French, J.E., and Spalding, J.W. (1999). Genetically altered mouse models for identifying carcinogens. IARC Sci. Publ. 146, 123–150. [PubMed: 10353386]
  60. Trempus, C.S., Mahler, J.F., Ananthaswamy, H.N., Loughlin, S.M., French, J.E., and Tennant, R.W. (1998). Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse. J. Invest. Dermatol. 111, 445–451. [PubMed: 9740239]
  61. White, G.T., and Mullin, K.B. (1967). Diisopropylcarbodiimide. U.S. Patent No. 3352908.
  62. Williams, D.A. (1971). A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27, 103–117. [PubMed: 5547548]
  63. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics 28, 519–531. [PubMed: 5037867]
  64. Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. (1999). Induction of micronucleated erythrocytes in rodents by diisopropylcarbodiimide and dicyclohexylcarbodiimide: Dependence on exposure protocol. Environ. Mol. Mutagen. 33, 65–74. [PubMed: 10037325]
  65. Witt, K.L., Knapton, A., Wehr, C.M., Hook, G.J., Mirsalis, J., Shelby, M.D., and MacGregor, J.T. (2000). Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 36, 163–194. [PubMed: 11044899]
  66. Wright, J.T., Hansen, L., Mahler, J., Szczesniak, C., and Spalding, J.W. (1995). Odontogenic tumours in the v-HA-ras (TG.AC) transgenic mouse. Arch. Oral Biol. 40, 631–638. [PubMed: 7575235]
  67. Wyde, M.E., Braen, A.P.J.M., Hejtmancik, M., Johnson, J.D., Toft, J.D., Blake, J.C., Cooper, S.D., Mahler, J., Vallant, M., Bucher, J.R., and Walker, N.J. (2004). Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice. Toxicol. Sci. 82, 34–45. [PubMed: 15282402]
  68. Zeiger, E. (1998). Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance. Regul. Toxicol. Pharmacol. 2, 85–95. [PubMed: 9927558]
Copyright Notice

This is a work of the US government and distributed under the terms of the Public Domain

Bookshelf ID: NBK576162
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (395K)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...